Previous 10 | Next 10 |
NEW YORK, June 30, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointments of Dr. Henry D. Cremisi and Joy Goudie, Esq. to the...
A Deeper Look Reveals New Concerns and Adds To Our Conviction Zynex (NASDAQ: ZYXI ) shares are up 150% year to date vs the Health Care Select SPDR ETF (NYSE: XLV) at -2%. We believe ZYXI's outperformance is a function of retail investor complacency combined with sell-side analyst careless...
NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that its CEO, Michael Feldschuh, will be a panelist in Maxim Group an...
NEW YORK, May 22, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that blood volume outcome data has been published in the scientific j...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
Takeda Teams Up with ProThera on IAIP Therapy Takeda Pharmaceutical Company Limited ( TAK ) announced inking a new deal with ProThera Biologics for the purpose of developing IAIP therapy. This plasma-derived therapy is intended to be used for treating acute inflammatory conditions. Both th...
New York, April 23, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that the United States Department of Defense (DOD) has awarded th...
Bellerophon Therapeutics (NASDAQ: BLPH ) +472% on FDA nod for emergency use of INOpulse for Covid-19. More news on: Bellerophon Therapeutics, Inc., Rand Capital, GenMark Diagnostics, Inc., Stocks on the move, Read more ...
Daxor (NYSEMKT: DXR ) announces the first use of its BVA-100 test to guide volume treatment in COVID-19 patients and released a clinical protocol for fluid guidance for the same. More news on: Daxor Corporation, Healthcare stocks news, Read more ...
New Clinical Protocol for Volume-Guided Therapy Helps Combat Coronavirus NEW YORK, March 20, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, ...
News, Short Squeeze, Breakout and More Instantly...
The Hematocrit Feature Will Be Integrated Into A Future Generation Blood Volume Analyzer (BVA) Oak Ridge, TN, July 24, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that Daxor has received a $550K matc...
Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration Oak Ridge, TN, July 11, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BV...
2024-06-27 22:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...